SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126
http://www.w3.org/2000/01/rdf-schema#comment
"MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab."
xsd:string
http://purl.uniprot.org/uniprot/#_42742281DE061F0C3676A39DD6F12404B170C596772678B304B24AAF2FFEA35525DD4AAFA92ECC3AB8F4C7F8D9FE8A46
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126
http://purl.uniprot.org/uniprot/A0A384ME80
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126
http://purl.uniprot.org/uniprot/#_A0A384ME80-mappedCitation-31965001
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BEA1A5692FE61C0D1BE53F85AA181F6278D77034885BAFE0F9182EBD89569B76666C51DB050DC046A795BFD4417DB126